Objective: To compare patterns of inpatient and outpatient antibiotic use between patients who awaited urine culture results and patients whose urine specimens had been submitted for culture and were screened using the CLINITEK AUWi System.
habits and current guidelines regarding UTI treatment resulted in only moderate improvement in adherence to guidelines. The results of another study of resident physicians revealed that the majority of residents were prescribing antibiotics even when they knew it was not indicated to do so. 12 One option to improve the appropriate use of antibiotics in the context of suspected UTI would be to ensure that healthcare professionals have timely information regarding laboratory results for the patient, to limit empirical treatment. As a quality improvement intervention, NYU Lutheran Medical Center in Brooklyn, NY, began using the CLINITEK AUWi System (Siemens AG) in 2014 to screen out urine specimens that test negative. This intervention is intended to reduce the number of cultures performed, thus providing physicians with rapid presumptive results, minimizing the use of unnecessary antibiotics, improving patient care, and reducing costs.
The CLINITEK AUWi System has demonstrated effectiveness in flagging urine specimens that have yielded negative results before they can be mistakenly sent for culture, thus reducing the total number of cultures performed and decreasing length of stay in the hospital. 13 As a result, we hypothesized that the use of this screening method would impact physician decision making in antibiotic management, resulting in a shorter duration of antibiotic treatment. This study compared patterns of inpatient and outpatient antibiotic use between patients whose urine specimens submitted for culture were screened using the CLINITEK AUWi System and patients who awaited urine culture results. This article also describes the impact on antibiotic management of urine culture screening using the CLINITEK AUWi System.
Materials and Methods

Study Population
We performed this study using records from inpatients at NYU Lutheran Medical Center, a 450-bed community teaching hospital in Brooklyn, NY.
Study Design
This study used a quasi-experimental retrospective cohort design to assess the impact on antibiotic usage of urine screening to determine the need for culture, using the CLINITEK AUWi System. This is a secondary analysis of data collected for a previously published study, 13 which focused on the impact of the CLINITEK AUWi System on length of stay.
The purpose of the current study was to examine the effect of the implementation of the CLINITEK AUWi System as a urine culture screening method on antibiotic prescribing patterns in our inpatient setting. The CLINITEK AUWi System combines an automated urine chemistry analyzer and a formed element analyzer. It includes a quantification of bacteria per µL and thus was implemented as a urine culture screening method, to reduce costs and time delays associated with urine culture.
Because the CLINITEK AUWi System is intended to screen out urine specimens with negative results without the need for culture results, it has high specificity but low sensitivity. This is appropriate because specimens with negative results will not receive further screening, whereas those with positive results from the CLINITEK AUWi System will be sent to culture, whereupon any false positives from the screening will be detected.
Before the initiation of this retrospective study, the CLINITEK AUWi System was validated as a urine culture screening test in our laboratory according to the College of American Pathologists (CAP) performance specifications and those of the New York Department of Health. Before clinical use, the laboratory tested multiple urine specimens from patients suspected of infection against urine culture performed at an external laboratory, defining positive urine cultures as those reported at 10 5 CFU per mL or higher.
Based on this analysis, the laboratory chose 325 bacteria per µL as the cutoff because this was the highest value that did not cause an unacceptable number of false-negative results. This cutoff is similar to those chosen by other laboratories. 14 Because the current article focuses on the clinical use of the CLINITEK AUWi System, all data for this paper came from clinical applications of urine culture and urine screening, rather than from the validation process.
Patient records were eligible for analysis if the patient had been admitted to the hospital from 1 month before to 1 month after implementation of the CLINITEK AUWi System for urine screening (November 1, 2014-January 1, 2015) and had had a urine specimen sent to the laboratory for analysis or culture. Patient records were excluded if the patients had signed out against medical advice or died during their stay. A total of 5110 patients were deemed eligible to participate in the study, of which 306 patients were randomly selected for electronic medical record (EMR) review. Data were collected on patient age, sex, comorbidities, length of stay (hours), length of inpatient and outpatient treatment (days), type and route of administration of antibiotics used, and urine culture and screening results.
Per hospital protocol, all urine specimens from patients in the preimplementation group had been sent out to an external laboratory for culture, whereas those from patients in the postimplementation group were screened using the CLINITEK AUWi System. Specimens were sent to culture only if their screening results were positive. The presumptive-positive or -negative screening results were uploaded to the EMR within 30 minutes of specimen processing. If the urine specimen yielded a negative screening result, it was not sent to culture. In this case, a negative result was reported with an interpretive comment as follows: "Presumptive negative result for bacteria based on established and validated screening algorithms and protocols using flow cytometric analysis. Culture not performed. Clinical correlation warranted." If the urine specimen tested positive, the specimen was sent to an external laboratory for culture, and the results were uploaded to the EMR when received back from the external laboratory, 48 to 72 hours later. All physicians were notified via memorandum of the changes in the urine specimen processing procedure before implementation of the CLINITEK AUWi System. After the instrument was implemented, the screening result was not compared against culture results because only the specimens with a positive screening result were sent to culture. This retrospective study was approved by the NYU Lutheran Medical Center Institutional Review Board.
Data Analysis
For the purposes of analysis, patients were classified into 3 categories: antibiotics started after culture, antibiotics changed after culture, and antibiotics stopped after culture. Participants were classified as having started antibiotics after culture if they were not taking antibiotics before culture but later had an antibiotic listed in their medical records after culture. Participants were classified as having had their antibiotics changed if the antibiotics listed before screening and after screening or before culture and after culture were not identical. They were classified as having had antibiotics stopped if they had an initial antibiotic listed before culture and no longer had an antibiotic listed as a treatment after culture. The number of patients in each category was compared between the preimplementation and postimplementation groups. Statistical significance was analyzed using the χ 2 test or Fisher exact test, as appropriate.
Also, participants in the postimplementation group were further categorized into 3 supplementary classifications: antibiotics started after screening, antibiotics changed after screening, and antibiotics stopped after screening. Classification into these categories was similar to the procedure described previously herein, using pre-and postimplementation screening as the time frame. We did so to assess the distribution of antibiotic usage among the postimplementation group.
Descriptive statistics were calculated for the duration of inpatient treatment, duration of outpatient treatment, and length of stay among the entire population and among those who received antibiotics. We used the Fisher exact test and Mann-Whitney U test, as appropriate, to assess the differences between antibiotic usage among pre-and postimplementation groups. Descriptive statistics were also obtained for those who were ever given antibiotics, those who were given antibiotics intravenously, and those who were given or prescribed antibiotics at the time of hospital discharge. All statistical analysis was performed using the R statistical language (version 3.2.3).
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Results
Demographics
A total of 304 EMRs that included documented urine specimens were included in the study (2 additional charts were collected but removed from analysis due to incomplete or inconsistent data). A total of 168 individuals were in the preimplementation group and 136 were in the postimplementation group. Nearly half of all patients had a urinary tract disorder in the diagnostic differential, and 32.6% of patients were treated with antibiotics. There were no statistically significant differences between the pre-and postimplementation groups in terms of age, sex, and medical history (urinary tract disorder in diagnostic differential, Foley catheter placement during stay, diabetes mellitus, urolithiasis, neurogenic bladder, immune status, sickle cell anemia, and chronic kidney disease). However, the preimplementation group had a higher proportion of structural abnormalities of the urinary tract ( Table 1) .
When analysis was limited to those who were treated with antibiotics during their stay, the pre-and postimplementation groups, again, were demographically similar to one another. The only exception was that the preimplementation group had a higher proportion of urinary tract structural abnormalities ( Table 1) .
Effect of the CLINITEK AUWi System on Duration of Inpatient and Outpatient Antibiotic Use
Although a similar proportion of patients in the pre-and postimplementation groups were prescribed antibiotics (35.1% vs 29.4%, P = 0.35), the postimplementation group had a significantly shorter length of stay in hours. The median inpatient antibiotic treatment duration was lower for those in the postimplementation group (4 days vs 5 days in the preimplementation group; P = .04), whereas the postimplementation group had a longer duration of outpatient antibiotic treatment ( Table 2) .
Changes in Antibiotic Management Associated With Use of the CLINITEK AUWi System
Of the patients in the preimplementation group who received antibiotics, the vast majority (88%) were receiving antibiotics before the culture results were obtained. After the culture results came back from the laboratory, more than one quarter of patients (16 [27%] ) in the preimplementation group had their antibiotic stopped, whereas more than one third (21 [38%]) had their antibiotic changed.
In the postimplementation group, three quarters of patients (30 [75%]) had been taking antibiotics before screening. More than one quarter of these (11 [28%]) were prescribed a different antibiotic after receiving the screening results, whereas very few (2 [5%]) had their antibiotics stopped. Twenty percent of patients (n = 8) were prescribed antibiotics only after the screening results came back.
Of those in the postscreening group whose specimens were cultured, nearly all (25 [96%]) were taking an antibiotic, of whom 4 had their antibiotic stopped and half (13, [50%]) had it changed after the culture result came back. Differences between the pre-and postimplementation groups in patterns of antibiotic use (start, stop, or change in use) after culture were not statistically significant ( Table 3) .
Conclusion
In our study results, we found differences in antibiotic management between the inpatient population before and after implementation of the CLINITEK AUWi System for testing of urine specimens before they are sent to be cultured. Our results revealed a shorter inpatient treatment course and an increased outpatient treatment course in the postimplementation group. A possible explanation of this finding is that suspected UTIs were better managed in the postimplementation group as a result of quicker turnaround times for urine culture screenings.
Also, screening noticeably affected physician clinical decision making because 21 of the patients studied (70%) had antibiotics stopped, 2 started, 8 or changed 11 after the screening result. Further, the pre-and postimplementation groups showed no significant change in the decisions of their treating physicians to stop, start, or change their antibiotic regimens after receiving culture results ( Table 3) . This finding is in concordance with what we expected to see because healthcare providers who would have presumed the urine culture results to be positive based on clinical findings would be expected to wait for culture sensitivity to trigger changes in their management behaviors.
We also discovered a significantly shorter median length of stay in the postimplementation population (a median decrease of 103 hours). Again, this finding could be explained by the additional finding that the healthcare providers were able to make quicker decisions regarding clinical management in the postimplementation group because the results of screening returned within 30 minutes rather than multiple days. It should be noted that we also discovered a decrease in length of stay for the entire postimplementation population, which was described in detail in a previous study. 13 Our findings have important implications for healthcare costs, especially because we report a shorter length of stay in the postimplementation group. In a recent comparison of pharmaceutical treatment costs among inpatient therapy, outpatient therapy, and emergency department treatment for complicated UTIs, the mean pharmacy costs for emergency department and inpatient care were greater than $1000 more per patient for the course of their treatment versus outpatient therapy. 16 Of note, the cost per day of an inpatient hospital stay is estimated to be $2475 per day in New York State on average, 17 making efforts to shift inpatient care to outpatient care essential to management planning. Our results suggest that the use of urine screening before culture may help to reduce hospital and patient costs by decreasing the length of inpatient stays, as well as allowing a more appropriate treatment regimen to begin sooner than with the traditional use of culture only.
Our sample size of 304 randomly selected patient records is one of the strengths of this study because it yielded a diverse patient population in terms of age, sex, and clinical characteristics. These patients had been admitted during a 2-month time frame and were similar in demographic and comorbidity characteristics. As with all retrospective, observational studies, confounding by unmeasured factors could have contributed to the results we derived; however, our pre-and postimplementation groups had similar data in many important categories.
Implications
Our results have important policy implications regarding the medical management of suspected UTIs. Healthcare providers that have access to urine screening in their hospital laboratories could be encouraged to focus treatment efforts around those screening results, to reduce inpatient hospital stays and unnecessary antibiotic use.
To complement the reduction of inpatient length of stay, the length of antibiotic treatment could be reduced by improving physician management and decisionmaking skills with the use of treatment algorithms and targeted education campaigns. A randomized control trial involving nursing home residents with suspected UTIs found that a multifaceted approach that targeted physician educational development was successful in reducing the number and amount of antibiotics prescribed to those residents. 18 Further research involving this topic would be helpful to analyze cost comparisons in antibiotic choice when healthcare providers have access to screening technology. A prospective study analyzing physician decision making regarding UTI treatment using urine screening devices would be valuable in assessing the accuracy of initial antibiotic choices. We believe that such a study would also provide further evidence for the efficacy of these devices in shortening mean length of stay. Specific attention to physician decision making in the outpatient setting in empiric treatment of UTIs could further demonstrate the benefit of using this technology as a screening method.
Our findings support the universal use of a urine culture screening method. Reduction of inpatient stay and decreased inpatient antibiotic treatment days would likely lead to a substantial reduction in treatment costs across healthcare settings. Using this screening method as a standard of care has the potential to reduce unnecessary testing, to improve diagnostic accuracy, and to reduce the excess administration of antibiotics. LM
